Development and validation of nomograms based on the SEER database for the risk factors and prognosis of distant metastasis in gastric signet ring cell carcinoma

Haomin Shi,Huilian Yang,Su Yan,Qi Zhang,Xingbin Wang
DOI: https://doi.org/10.1097/md.0000000000040382
IF: 1.6
2024-11-06
Medicine
Abstract:Gastric cancer is the fifth most common malignant tumor worldwide and ranks third in cancer-related mortality. Some gastric cancer lesions contain components of signet ring cell carcinoma (SRCC). [ 1 ] The pathological classification of gastric signet ring cell carcinoma (GSRC) corresponds to the low adhesive type in the World Health Organization classification, diffuse type in the Laurén classification, undifferentiated type in the Nakamura classification, and poorly differentiated adenocarcinoma type in the Japanese Gastric Cancer Association classification. [ 2 ] As a subtype of gastric adenocarcinoma, GSRC has its own distinctive clinicopathological characteristics. The incidence of GSRC has been increasing annually, accounting for 35% to 45% of gastric adenocarcinoma cases. [ 3 ] The prognosis of GSRC differs significantly depending on the stage, with poor prognosis for advanced GSRC and better prognosis for early GSRC compared to conventional gastric adenocarcinoma. Accordingly, the treatment strategies also differ. GSRC usually presents with lymph node and distant organ metastasis at the time of diagnosis. [ 4 ] Currently, postoperative treatment for GSRC mainly relies on chemotherapy, but the efficacy is generally poor for most GSRC patients. Adjuvant chemotherapy or neoadjuvant chemoradiotherapy can be used in the perioperative period, but many patients still develop resistance and metastasis. These treatment approaches have limited impact on improving overall survival rates, and the median survival period in most clinical trials is 12 to 20 months. [ 5–7 ] Therefore, it is imperative to establish an accurate model for assessing the prognosis of GSRC patients with distant metastasis. Previous studies have shown that TNM staging, tumor size, chemotherapy, peritoneal metastasis, and microsatellite instability are related to the prognosis of GSRC patients. [ 8 ] However, reliable data on the relationship between the clinicopathological characteristics of GSRC and distant metastasis are limited, and no predictive model has been established for predicting the prognosis of GSRC patients with distant metastasis.
medicine, general & internal
What problem does this paper attempt to address?